Proteome profiling of early gestational plasma reveals novel biomarkers of congenital heart disease

Abstract Prenatal diagnosis of congenital heart disease (CHD) relies primarily on fetal echocardiography conducted at mid‐gestational age—the sensitivity of which varies among centers and practitioners. An objective method for early diagnosis is needed. Here, we conducted a case–control study recrui...

詳細記述

書誌詳細

主要な著者:	Ya‐Nan Yin, Li Cao, Jie Wang, Yu‐Ling Chen, Hai‐Ou Yang, Su‐Bei Tan, Ke Cai, Zhe‐Qi Chen, Jie Xiang, Yuan‐Xin Yang, Hao‐Ran Geng, Ze‐Yu Zhou, An‐Na Shen, Xiang‐Yu Zhou, Yan Shi, Rui Zhao, Kun Sun, Chen Ding, Jian‐Yuan Zhao
フォーマット:	Artigo
言語:	Inglês
出版事項:	Springer Nature 2023-10-01
シリーズ:	EMBO Molecular Medicine
主題:	congenital heart disease plasma proteomics gestational
オンライン･アクセス:	https://doi.org/10.15252/emmm.202317745
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!